News
Moderna isn’t giving up on the combo shot entirely—it plans to resubmit later this year after it collects more data from its ...
Moderna said on Wednesday it has withdrawn an application seeking approval for its flu and COVID combination vaccine ...
5d
Live Science on MSN2-in-1 COVID-flu vaccine looks promising, but approval could be delayedLate-stage trial data suggest that a new COVID-flu vaccine offers good protection against both infections, but experts expect ...
Moderna Inc. said it has “voluntarily” withdrawn its application for regulatory approval for its combination Covid and flu ...
Moderna said on Wednesday it has withdrawn an application seeking approval for its flu and COVID combination vaccine ...
This week, two new leaders at the US Food and Drug Administration announced plans to limit access to covid vaccines, arguing ...
The announcement, which followed the FDA setting new guidelines on COVID vaccine approvals, erased the stock’s gains from ...
The notice came shortly after an advisory panel meeting at which members debated the pros and cons of asking manufacturers to ...
With Covid cases resurfacing, the District Health Department has started monitoring cases of influenza and seasonal flu more ...
Federal health officials will no longer routinely approve annual COVID-19 shots for younger adults and children who are ...
SHELTON, CT / ACCESS Newswire / May 22, 2025 / Dr. Anil Diwan, President of NanoViricides, Inc. (NYSE Amer.:NNVC ) (the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results